Aconitine compounds, compositions, uses, and preparation thereof
    1.
    发明授权
    Aconitine compounds, compositions, uses, and preparation thereof 有权
    乌头碱化合物,组合物,用途及其制备

    公开(公告)号:US09085536B2

    公开(公告)日:2015-07-21

    申请号:US13421809

    申请日:2012-03-15

    IPC分类号: A61K31/439 C07D221/22

    摘要: Compound derivatives of aconitine are provided, in particular derivatives that modulate the activity of sodium channels. Also provided are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier. The subject compounds are useful in treatments, including treatments to modulate neuronal activity or to bring about muscular relaxation. The compounds also find use in the treatment of subjects suffering from a voltage-gated sodium channel-enhanced ailment or from pain. Further methods are provided for the preparation of the aconitine derivatives.

    摘要翻译: 提供乌头碱的复合衍生物,特别是调节钠通道活性的衍生物。 还提供了包含本发明化合物和药学上可接受的载体的药物组合物。 主题化合物可用于治疗,包括调节神经元活动或引起肌肉松弛的治疗。 该化合物还可用于治疗患有电压门控钠通道增强性疾病或疼痛的受试者。 提供了用于制备乌头碱衍生物的其它方法。

    Tubulysin D Analogues
    3.
    发明申请
    Tubulysin D Analogues 审中-公开
    Tubulysin D类似物

    公开(公告)号:US20110263650A1

    公开(公告)日:2011-10-27

    申请号:US12669672

    申请日:2008-07-21

    摘要: The present invention provides novel tubulysin analogues, methods of making and methods of using such analogues and conjugates thereof. The essential features for the potent cytotoxicity of tubulysin D have been established for the first time by the synthesis and evaluation of a series of analogues. By identifying functionality that surprisingly is not necessary for activity, highly potent cell-growth inhibitors have been developed that are smaller and considerably more stable than tubulysin D.

    摘要翻译: 本发明提供新型的微管蛋白酶类似物,制备方法以及使用其类似物和缀合物的方法。 通过合成和评估一系列类似物,首次建立了管状细胞毒素D的有效细胞毒性的基本特征。 通过鉴定出令人惊讶地不是活性必需的功能,已经开发出高效的细胞生长抑制剂,它们比小管状蛋白酶D更小和更稳定。